Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kreis Leslie W.
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fletcher Aaron G.L.
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Wallace Peggy
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Khattar Jack A.
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RICHSTONE ELLEN B
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Monia Brett P
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Doyle John Brendan
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ricciardi Lisa
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Caggiano Anthony
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Doyle John Brendan
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ricciardi Lisa
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Caggiano Anthony
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ricciardi Lisa
Cognition Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-AIGH Capital Management, LLC(4.8%),Orin H(4.8%)
Cognition Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Pathstone Family Office, LLC 271957427(7.53%)
Cognition Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BIOS CAPITAL MANAGEMENT, LP(19.4%),BIOS ADVISORS GP, LLC(19.4%), etc.
Cognition Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Bios Clinical Opportunity Fund, LP
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kreis Leslie W.
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fletcher Aaron G.L.
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kreis Leslie W.
No Data
No Data